http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-202102240-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_49a3f1c7cf8da8af34cc22f1691365da |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-18 |
filingDate | 2019-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e61650f352755df9fc436f291476a79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fcd498cd3d0f2d1dc297228bd91c7e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_272604f52f6d35f2fa82d7c06e8c67da |
publicationDate | 2021-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | TW-202102240-A |
titleOfInvention | USE OF EMBLICA EXTRACTION IN PREPARINGPHARMACEUTICAL COMPOSITION FOR REDUCING PRODUCTION OF AMYLOID β-40 ASSOCIATED WITH NEURODEGENERATIVE DISEASE |
abstract | A use of an emblica extraction in preparing a pharmaceutical composition for treating or preventing a neurodegenerative disease comprises providing the pharmaceutical composition that includes the emblica extraction to the cell, so that the generation of one or more biological factors in this cell is lower than that in other cell without receiving the pharmaceutical composition that includes the emblica extraction. |
priorityDate | 2019-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 120.